HEMPALTA CORP (HEMP.CA) Stock Fundamental Analysis

TSX-V:HEMP • CA42371M1041

0.015 CAD
0 (0%)
Last: Feb 19, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

0

HEMP gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. Both the profitability and financial health of HEMP have multiple concerns. HEMP does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year HEMP has reported negative net income.
  • In the past year HEMP has reported a negative cash flow from operations.
HEMP.CA Yearly Net Income VS EBIT VS OCF VS FCFHEMP.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

Industry RankSector Rank
ROA -312%
ROE -730.96%
ROIC N/A
ROA(3y)-46.23%
ROA(5y)N/A
ROE(3y)-71.12%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HEMP.CA Yearly ROA, ROE, ROICHEMP.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 -50 -100 -150

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for HEMP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HEMP.CA Yearly Profit, Operating, Gross MarginsHEMP.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • HEMP does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for HEMP has been increased compared to 1 year ago.
  • The debt/assets ratio for HEMP is higher compared to a year ago.
HEMP.CA Yearly Shares OutstandingHEMP.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M
HEMP.CA Yearly Total Debt VS Total AssetsHEMP.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 1M 2M 3M 4M 5M

2.2 Solvency

  • Based on the Altman-Z score of -11.33, we must say that HEMP is in the distress zone and has some risk of bankruptcy.
  • HEMP has a Debt/Equity ratio of 0.85. This is a neutral value indicating HEMP is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF N/A
Altman-Z -11.33
ROIC/WACCN/A
WACC7.13%
HEMP.CA Yearly LT Debt VS Equity VS FCFHEMP.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 1M -1M 2M -2M 3M

2.3 Liquidity

  • HEMP has a Current Ratio of 0.08. This is a bad value and indicates that HEMP is not financially healthy enough and could expect problems in meeting its short term obligations.
  • HEMP has a Quick Ratio of 0.08. This is a bad value and indicates that HEMP is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
HEMP.CA Yearly Current Assets VS Current LiabilitesHEMP.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • HEMP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -505.38%.
  • The Revenue for HEMP has decreased by -37.06% in the past year. This is quite bad
EPS 1Y (TTM)-505.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23.33%
Revenue 1Y (TTM)-37.06%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-71.19%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HEMP.CA Yearly Revenue VS EstimatesHEMP.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 100K 200K 300K 400K 500K

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • HEMP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HEMP.CA Price Earnings VS Forward Price EarningsHEMP.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HEMP.CA Per share dataHEMP.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1 -0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • HEMP does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HEMPALTA CORP

TSX-V:HEMP (2/19/2026, 7:00:00 PM)

0.015

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners25.91%
Ins Owner ChangeN/A
Market Cap1.68M
Revenue(TTM)350.00K
Net Income(TTM)-6.94M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.8
P/FCF N/A
P/OCF N/A
P/B 1.77
P/tB 3.99
EV/EBITDA N/A
EPS(TTM)-0.19
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0
BVpS0.01
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -312%
ROE -730.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-46.23%
ROA(5y)N/A
ROE(3y)-71.12%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z -11.33
F-Score3
WACC7.13%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-505.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-37.06%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-71.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-14.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5671.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4439.2%
OCF growth 3YN/A
OCF growth 5YN/A

HEMPALTA CORP / HEMP.CA FAQ

Can you provide the ChartMill fundamental rating for HEMPALTA CORP?

ChartMill assigns a fundamental rating of 0 / 10 to HEMP.CA.


What is the valuation status of HEMPALTA CORP (HEMP.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to HEMPALTA CORP (HEMP.CA). This can be considered as Overvalued.


How profitable is HEMPALTA CORP (HEMP.CA) stock?

HEMPALTA CORP (HEMP.CA) has a profitability rating of 0 / 10.


How financially healthy is HEMPALTA CORP?

The financial health rating of HEMPALTA CORP (HEMP.CA) is 0 / 10.